Rui Ding

1.1k total citations · 1 hit paper
40 papers, 792 citations indexed

About

Rui Ding is a scholar working on Molecular Biology, Cancer Research and Computer Networks and Communications. According to data from OpenAlex, Rui Ding has authored 40 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Computer Networks and Communications. Recurrent topics in Rui Ding's work include Neural Networks Stability and Synchronization (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Distributed Control Multi-Agent Systems (3 papers). Rui Ding is often cited by papers focused on Neural Networks Stability and Synchronization (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Distributed Control Multi-Agent Systems (3 papers). Rui Ding collaborates with scholars based in China, United Kingdom and Belgium. Rui Ding's co-authors include Zhengxiao Guo, A. Wilson, Yi‐Zhou Jiang, Zhi‐Ming Shao, Ying Xu, Yiping Wang, Yi Xiao, Tian‐Jian Yu, Peter Tom Jones and Patrick Wollants and has published in prestigious journals such as PLoS ONE, Cell Metabolism and Journal of Controlled Release.

In The Last Decade

Rui Ding

34 papers receiving 766 citations

Hit Papers

Emerging therapies in cancer metabolism 2023 2026 2024 2025 2023 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rui Ding China 12 317 317 192 158 140 40 792
Zhiyang Wang China 21 393 1.2× 394 1.2× 201 1.0× 208 1.3× 158 1.1× 66 1.2k
Lihong Dong China 18 502 1.6× 80 0.3× 157 0.8× 168 1.1× 84 0.6× 77 967
Yulun Wu China 17 340 1.1× 313 1.0× 55 0.3× 123 0.8× 82 0.6× 77 812
Qingya Li China 16 141 0.4× 240 0.8× 456 2.4× 82 0.5× 60 0.4× 36 858
Jianjun Qu China 18 465 1.5× 166 0.5× 362 1.9× 138 0.9× 124 0.9× 85 998
Hengcheng Zhang China 16 192 0.6× 133 0.4× 57 0.3× 87 0.6× 48 0.3× 62 681
Zhenyao Xu China 20 157 0.5× 69 0.2× 70 0.4× 302 1.9× 164 1.2× 98 1.2k
Yuheng Jiang China 14 138 0.4× 91 0.3× 110 0.6× 122 0.8× 104 0.7× 25 626
Tariq Aziz Canada 22 256 0.8× 82 0.3× 64 0.3× 152 1.0× 84 0.6× 73 1.2k

Countries citing papers authored by Rui Ding

Since Specialization
Citations

This map shows the geographic impact of Rui Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Ding more than expected).

Fields of papers citing papers by Rui Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Ding. The network helps show where Rui Ding may publish in the future.

Co-authorship network of co-authors of Rui Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Rui Ding. A scholar is included among the top collaborators of Rui Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Ding. Rui Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Ming, et al.. (2025). Zuoqing granules attenuate ulcerative colitis via macrophage polarization modulation: involvement of the PPAR-γ/NF-κB/STAT1 signaling axis. Frontiers in Pharmacology. 16. 1646545–1646545. 1 indexed citations
2.
Zhang, Wenjie, et al.. (2025). Pathogenesis of metabolic dysfunction-associated steatotic liver disease and donor liver damage. PubMed. 4(4). 100195–100195.
3.
Guo, Qingdong, Qi Wang, Hong Zhao, et al.. (2025). Fibulin-1 deficiency alleviates liver fibrosis by inhibiting hepatic stellate cell activation via the p38 MAPK pathway. Cellular and Molecular Life Sciences. 82(1). 192–192. 2 indexed citations
4.
Jiang, Yanqun, Wei Zhang, Zhengshuyan Wang, et al.. (2025). Simulation analysis of ICRF heating scenarios for CFEDR. Plasma Science and Technology. 27(10). 104012–104012.
5.
Ding, Rui, et al.. (2025). Satellite-assisted 6G wide-area edge intelligence: dynamics-aware task offloading and resource allocation for remote IoT services. Science China Information Sciences. 68(2). 1 indexed citations
6.
Huang, Yun, et al.. (2024). Role of glucose metabolic reprogramming in colorectal cancer progression and drug resistance. Translational Oncology. 50. 102156–102156. 12 indexed citations
7.
Guo, Kehua, Xiangyuan Zhu, Gerald Schaefer, Rui Ding, & Hui Fang. (2024). Self-supervised memory learning for scene text image super-resolution. Expert Systems with Applications. 258. 125247–125247. 2 indexed citations
8.
Ding, Rui, et al.. (2024). Experimental and numerical investigation of transpiration cooling with gradient porosity layout for the thermal protection of nose cone. Aerospace Science and Technology. 149. 109140–109140. 20 indexed citations
9.
Wu, Zheng, Kehua Guo, Entao Luo, et al.. (2024). Medical long-tailed learning for imbalanced data: Bibliometric analysis. Computer Methods and Programs in Biomedicine. 247. 108106–108106. 9 indexed citations
10.
Ding, Jia-Han, Yi Xiao, Fan Yang, et al.. (2024). Guanosine diphosphate–mannose suppresses homologous recombination repair and potentiates antitumor immunity in triple-negative breast cancer. Science Translational Medicine. 16(728). eadg7740–eadg7740. 11 indexed citations
11.
Wang, Hao, Fan Cui, Qianqian Song, et al.. (2023). Enhancing prognostic accuracy in head and neck squamous cell carcinoma chemotherapy via a lipid metabolism-related clustered polygenic model. Cancer Cell International. 23(1). 164–164. 4 indexed citations
12.
Wu, Zheng, Kehua Guo, Sheng Ren, et al.. (2023). GREB: gradient re-balanced loss for long-tailed multi-lable classification. Journal of Ambient Intelligence and Humanized Computing. 14(6). 7937–7948.
13.
Zhang, Huiying, et al.. (2023). miR-146a-5p Promotes the Inflammatory Response in PBMCs Induced by Microcystin-Leucine-Arginine. Journal of Inflammation Research. Volume 16. 1979–1993. 3 indexed citations
14.
Tian, Zelin, Weixiang He, Zhibin Lin, et al.. (2023). The deubiquitinating enzyme USP19 facilitates hepatocellular carcinoma progression through stabilizing YAP. Cancer Letters. 577. 216439–216439. 27 indexed citations
15.
Ding, Rui, Yi Xiao, Miao Mo, et al.. (2022). Breast cancer screening and early diagnosis in Chinese women. Cancer Biology and Medicine. 19(4). 450–467. 42 indexed citations
16.
Tian, Zelin, Zhibin Lin, Wenlong Wu, et al.. (2022). Molecular pathogenesis: Connections between viral hepatitis-induced and non-alcoholic steatohepatitis-induced hepatocellular carcinoma. Frontiers in Immunology. 13. 984728–984728. 18 indexed citations
17.
Wang, Beilei, et al.. (2022). Perspectives of lipid metabolism reprogramming in head and neck squamous cell carcinoma: An overview. Frontiers in Oncology. 12. 1008361–1008361. 14 indexed citations
18.
Zhang, Jiyun, Rui Ding, Jinyu Zhou, et al.. (2022). Diagnostic potential of site-specific serotransferrin N-glycosylation in discriminating different liver diseases. Clinica Chimica Acta. 539. 175–183. 4 indexed citations
19.
Zhang, Wenjie, Wenlong Wu, Qiang Meng, et al.. (2022). Research Progress on Long Noncoding RNAs and N6-Methyladenosine in Hepatocellular Carcinoma. Frontiers in Oncology. 12. 907399–907399. 8 indexed citations
20.
Liu, Gang, Huan Zhang, Wenbing Zhu, et al.. (2020). HIV prevalence among 338,432 infertile individuals in Hunan, China, 2012-2018: A cross-sectional study. PLoS ONE. 15(9). e0238564–e0238564. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026